ADIPOQ and Chagas disease: Although the electrocardiogram is an established marker of severity of Chagas’ disease, the increased adiponectin levels found in patients with ECG abnormalities without systolic dysfunction suggest that adiponectin may help to identify patients at higher risk of developing systolic HF in this group.